Smart MXene/agarose hydrogel with photothermal property for controlled drug release

Smart hydrogels responsive to minimally invasive near-infrared (NIR) light have great potential in localized drug delivery for cancer treatment, but they still show some limitations such as low photothermal conversion, poor photothermal stability, and improper temperature range in biomedical applications. In this paper, the twodimensional MXene nanosheets with high photothermal conversion efficiency as well as photothermal stability was firstly prepared, then the MXene nanosheets and the therapeutic drug were embedded in the low-meltingpoint agarose hydrogel network to fabricate the drug-loaded MXene/agarose hydrogel (MXene@Hydrogel). With the addition of low concentration of MXene (20 ppm), the MXene@Hydrogel could quickly rise to 60 degrees C under NIR irradiation and melt to release the encapsulated drugs. Importantly, the drug on/off release and the kinetics could be easily controlled with varied agarose concentration, MXene concentration, light intensity, and exposure time. In addition, the drug doxorubicin retained the anticancer activity after released from the MXene@Hydrogel network under NIR irradiation. With the excellent biocompatibility, the newly fabricated NIR-responsive MXene@Hydrogel offers a novel way for the development of smart hydrogel-based drug delivery system for localized cancer treatment.

Automated summary

In this study, two-dimensional MXene nanosheets with high photothermal conversion efficiency and stability were successfully prepared and applied to a hydrogel drug delivery system, providing a new approach for localized cancer treatment.